![Stefan Metz, PhD](https://news.unchealthcare.org/wp-content/uploads/sites/1159/2020/06/dengue-fever-vaccine-delivered-with-nanotechnology-targets-all-four-virus-serotypes-image2-1-600x900.jpeg)
October 4, 2018
Dengue Fever Vaccine Delivered With Nanotechnology Targets All Four Virus Serotypes
A newly published study led by Stefan Metz, PhD, a research associate at the UNC School of Medicine, details how researchers used a nanoparticle vaccine platform to develop a tetravalent dengue virus vaccine capable of inducing balanced, type-specific neutralizing antibodies to each dengue virus serotype.